Peter Benton

Peter Benton is a seasoned pharmaceutical executive with a strong track record in running businesses with P&L responsibilities exceeding $200 million. He has led significant M&A activities for an $11 billion business and excels in developing and implementing corporate strategies. Benton has been instrumental in driving change efforts related to new drug launches at J&J. His demonstrated ability to set clear goals, devise effective strategies, and deliver exceptional results highlights his strong leadership, communication, creativity, and analytical skills. With an MBA from Wharton specializing in Finance and Strategy, Benton is known for his decisiveness, solution-oriented approach, and focus on results.

Benton's expertise spans strategic planning, acquisitions and divestitures, business development, new product development, fund raising, project management, resource management, portfolio management, business reengineering, and global manufacturing. He has honed his skills through extensive education and roles across various prestigious organizations, showcasing his depth of experience and knowledge in the pharmaceutical and business sectors.

Throughout his career, Benton has held key positions in renowned organizations, including President & Board Member at Worldwide Clinical Trials, Venture Mentor at CED, and Founder and Chairman at Flexible Medical Systems. His roles have ranged from Chief Operating Officer to Vice President of Research and Development at Johnson & Johnson, where he demonstrated his proficiency in leadership, strategic decision-making, and operational excellence. Benton's contributions extend to academia, where he served as an Adjunct Professor nurturing future generations of business leaders. His diverse background encompasses stints at Wharton Venture Partners, TRW, GE, and BioClinica, underlining his versatility and adaptability in various professional settings.